Search research articles
Contact Us
Filters
Showing results (131-140 of 134) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 134 results.
Antimicrobial Agents and Chemotherapy
|
May 5, 2010
Gag mutations can impact virological response to dual-boosted protease inhibitor combinations in antiretroviral-naïve HIV-infected patients
Lucile Larrouy, C Chazallon, R Landman, et al.
Lancet (London, England)
|
June 17, 1999
Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: a randomised controlled trial. ANRS 048 study group
Y Levy, C Capitant, S Houhou, et al.
Antiviral Therapy
|
February 22, 2000
Zidovudine resensitization and dual HIV-1 resistance to zidovudine and lamivudine in the delta lamivudine roll-over study
B Masquelier, D Descamps, I Carrière, et al.
AIDS (London, England)
|
April 14, 2010
Discordance between CD4 cell count and CD4 cell percentage: implications for when to start antiretroviral therapy in HIV-1 infected children
, K Boyd, David T Dunn, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 134) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 134 results.
Antimicrobial Agents and Chemotherapy
|
May 5, 2010
Gag mutations can impact virological response to dual-boosted protease inhibitor combinations in antiretroviral-naïve HIV-infected patients
Lucile Larrouy, C Chazallon, R Landman, et al.
Lancet (London, England)
|
June 17, 1999
Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: a randomised controlled trial. ANRS 048 study group
Y Levy, C Capitant, S Houhou, et al.
Antiviral Therapy
|
February 22, 2000
Zidovudine resensitization and dual HIV-1 resistance to zidovudine and lamivudine in the delta lamivudine roll-over study
B Masquelier, D Descamps, I Carrière, et al.
AIDS (London, England)
|
April 14, 2010
Discordance between CD4 cell count and CD4 cell percentage: implications for when to start antiretroviral therapy in HIV-1 infected children
, K Boyd, David T Dunn, et al.
Page
of 14